Search Results

Prescription Drug Safety and Effectiveness in Multiple Sclerosis (DRUMS)

• Authors : University of Manitoba; Dalhousie University; University of Saskatchewan ...

• Source: Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]Ng HS, Zhu F, Kingwell

Record details

Pharmacogenomics of Drug Safety in Multiple Sclerosis

• Authors : Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation; Genome Canada ...

• Source: Canadian Pharmacogenomics Network for Drug Safety: Genetic Factors Associated With Multiple Sclerosis

Record details

Strategies to Enhance the Intravenous Treatment Satisfaction and Drug Safety Awareness Among Patients with Multiple Sclerosis in Macedonia.

• Authors : Barbov I; University Clinic for Neurology, Skopje, Republic of Macedonia.; Korunoska J

Subjects: Assessment of Medication Adherence*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*administration & dosage ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*administration & dosage

• Source: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) [Pril (Makedon Akad Nauk Umet Odd Med Nauki)] 2018 Jul 01; Vol. 39 (1), pp. 115-121.Publisher: Makedonska akademija na naukite i umetnostite Country of Publication: North Macedonia NLM ID: 101677081 Publication Model: Print Cited Medium:

Record details

STRATEGIES TO ENHANCE THE INTRAVENOUS TREATMENT SATISFACTION AND DRUG SAFETY AWARENESS AMONG PATIENTS WITH MULTIPLE SCLEROSIS IN MACEDONIA.

• Authors : Barbov, Ivan¹ ; Korunoska, Jasmina¹; Bonevska, Valentina¹

Subjects: Medication safety; Multiple sclerosis

• Source: Contributions / Prilozi (1857-9345). 2018, Vol. 39 Issue 1, p115-121. 7p.

Record details

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

• Authors : López-Fauqued, M.; Campora, L.; Delannois, F.

Subjects: Reactogenicity; Safety; Vaccine

• Source: Vaccine. 37(18):2482-2493

Record details

Discovery of Novel β‑Arrestin Biased Sphingosine-1-Phosphate‑1 Receptor Agonists for the Treatment of Multiple Sclerosis

• Authors : Chang Yong Lee; Lizaveta Gotina; Jushin Kim

Subjects: Biochemistry; Medicine; Molecular Biology

Record details

Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database

• Authors : Xiping Yang; Yan Yan; Suyao Liu

Subjects: S1PR modulators; multiple sclerosis; FAERS

• Source: Frontiers in Pharmacology, Vol 15 (2024)

Record details

Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis

• Authors : Pierre Clavelou; Giovanni Castelnovo; Valérie Pourcher

Subjects: Multiple sclerosis; Cladribine tablets; Disease-modifying therapy

• Source: Neurology and Therapy, Vol 12, Iss 5, Pp 1457-1476 (2023)

Record details

Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment

• Authors : Terzi, M.; Helvacı, E.M.; Şen, S.

Subjects: safety; hypotension; leukocyte count

Record details

Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis

• Authors : Michael Hecker; Niklas Frahm; Uwe Klaus Zettl

Subjects: deep learning; drug-drug interactions; drug-food interactions

• Source: Pharmaceutics, Vol 16, Iss 1, p 3 (2023)

Record details